Northwestern Mutual Wealth Management
VBIV

Northwestern Mutual Wealth Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$1 – 3899
2024
Q2 		$1 Buy
+2
New +$1 ﹤0.01% 3482
2022
Q3 		– Sell
-2
Closed – – 3457
2022
Q2 		$0 Hold
2
– – ﹤0.01% 3540
2022
Q1 		$0 Sell
2
-26
-93% -$1.28K ﹤0.01% 3477
2021
Q4 		$2K Buy
+28
New +$2.36K ﹤0.01% 2975
2019
Q4 		– Sell
-50
Closed -$1K – 2666
2019
Q3 		$1K Buy
+50
New +$1.05K ﹤0.01% 2411

Northwestern Mutual Wealth Management's VBIV Position: Q3 2024 in Review

Northwestern Mutual Wealth Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 2 shares — an estimated $1 sold.

Northwestern Mutual Wealth Management first reported a position in VBIV in Q3 2019 and held it in 5 quarters. The position peaked at $2K in Q4 2021. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.

  • Northwestern Mutual Wealth Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 2 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $1.
  • Northwestern Mutual Wealth Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2019 and held it in 5 quarters.
  • Northwestern Mutual Wealth Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.